DEXAMETHASONE , -, -, MK-1022
MK-9999-01C
Phase 2 small_molecule active
Quick answer
DEXAMETHASONE , -, -, MK-1022 for Hepatoblastoma, Rhabdomyosarcoma is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Hepatoblastoma, Rhabdomyosarcoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active